NCT00109330 A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine Status COMPLETED Phase PHASE3
NCT00108095 A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting Status COMPLETED Phase PHASE2
NCT00108082 The CLEVER Study - Coreg And Left Ventricular Mass Regression Status COMPLETED Phase PHASE3
NCT00107718 Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00107081 Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting Status TERMINATED Phase PHASE3
NCT00105950 Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer Status COMPLETED Phase PHASE2
NCT00104416 Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures Status COMPLETED Phase PHASE3
NCT00104403 Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy Status COMPLETED Phase PHASE2
NCT00103922 Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease) Status COMPLETED Phase PHASE3
NCT00103727 Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia Status COMPLETED Phase PHASE2
NCT00103454 A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). Status COMPLETED Phase PHASE3
NCT00102882 Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate Status COMPLETED Phase PHASE4
NCT00102739 SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) Status COMPLETED Phase PHASE2
NCT00102726 SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy Status COMPLETED Phase PHASE2
NCT00101998 Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication Status COMPLETED Phase PHASE2
NCT00101985 Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) Status COMPLETED Phase PHASE2